STEVEN POUNDERS: Open Payments
NPI 1124073614 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 70 payments from 14 companies in 2025. Trend: 2023 $3,500 · 2024 $2,890 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 20 | $861 |
| ViiV Healthcare Company | 29 | $715 |
| EMD Serono, Inc. | 3 | $109 |
| Novo Nordisk Inc | 4 | $71 |
| PFIZER INC. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Theratechnologies Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| Napo Pharmaceuticals Inc | 1 | $21 |
Products named: DOVATO, CABENUVA, APRETUDE, Yeztugo, Biktarvy, PIFELTRO, PREVNAR 20, REXULTI.
Industry payments across TX — which companies pay providers there.
